Healio Blog
Published on September 10, 2026
Healio Blog: Meeting the Moment: Cellular Therapy’s Expanding Role in Autoimmune Disease
by ASTCT Staff
Cellular therapies have transformed the treatment of hematologic malignancies, and growing evidence suggests they may soon have a similarly profound impact on autoimmune and immunological disorders. In a recent Healio Q&A, Claudio G. Brunstein, MD, and David L. Porter, MD, discuss the expanding role of transplantation and cellular therapy in autoimmune disease and the opportunities and challenges facing this rapidly evolving field.
The conversation highlights the potential of immune-reset therapies, including autologous hematopoietic cell transplantation and emerging cellular therapies, to achieve durable disease control while reshaping how clinicians think about managing autoimmune conditions. Drs. Brunstein and Porter also emphasize the importance of multidisciplinary collaboration among transplant physicians, cellular therapy specialists, neurologists, rheumatologists, and other experts as these therapies move beyond oncology into new areas of patient care.
The discussion serves as a preview of ASTCT and the Colorado Blood Cancer Institute's inaugural Meeting on Transplantation and Cellular Therapy for Immunological Disorders, which will explore patient selection, toxicity management, long-term follow-up, and the future of cellular therapy in autoimmune disease.
Read the full article on Healio.
![]()